Phase I Study of Weekly LOC-paclitaxel Injection
Phase of Trial: Phase I
Latest Information Update: 06 Jun 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Malignant melanoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 25 May 2016 Status changed from completed to discontinued.
- 25 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.